Cancer Treatment for Everyone

New promise found in treating triple negative breast cancer

March 30, 2018

Triple negative breast cancer (TNBC) is a particularly aggressive form of breast cancer that lacks known targets for therapies, making it difficult to treat. However, a new study by a group of researchers and physician-scientists, led by Baylor College of Medicine, has identified a novel treatment strategy that may be effective for TNBC patients.

Many types of cancers are caused by receptors that promote the growth of cancers. But the receptors driving some cancer types like TNBC have remained elusive to scientists, until now.  In the current study, scientists at Baylor have discovered a pair of receptors that cooperate to drive this deadly disease. Therapies inhibiting these receptors in combination can dramatically shrink TNBCs, including those cancers that are resistant to standard chemotherapy.

Read More


Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us:

By clicking Submit, you agree to our Terms And Conditions and have read and acknowledge our Privacy Statement.